The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Open accessAbstract
The MDR1 (ABCB1) gene encodes a membrane-bound transporter that actively effluxes a wide range of compounds from cells. The overexpression of MDR1 by multidrug-resistant cancer cells is a serious impediment to chemotherapy. MDR1 is expressed in various tissues to protect them from the adverse effect of toxins. The pharmacokinetics of drugs that are also MDR1 substrates also influence disease outcome and treatment efficacy. Although MDR1 is a well conserved gene, there is increasing evidence that its polymorphisms affect substrate specificity. Three single nucleotide polymorphisms (SNPs) occur frequently and have strong linkage, creating a common haplotype at positions 1236C>T (G412G), 2677G>T (A893S) and 3435C>T (I1145I). The frequency of the synonymous 3435C>T polymorphism has been shown to vary significantly according to ethnicity. Existing literature suggests that the haplotype plays a role in response to drugs and disease susceptibility. This review summarizes recent findings on the 3435C>T polymorphism of MDR1 and the haplotype to which it belongs. A possible molecular mechanism of action by ribosome stalling that can change protein structure and function by altering protein folding is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Self-citationThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Self-citationThe NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Self-citationHoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Self-citationCrystal structure of the ribosome at 5.5 Å resolution
Yusupov, M. M., Yusupova, G. Z., Baucom, A., Lieberman, K., Earnest, T. N., Cate, J. H. D., & Noller, H. F. (2001) · Science · doi:10.1126/science.1060089 · Cited by 1,944
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Self-citationExpression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Self-citationSchinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Self-citationUeda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
Self-citationIdentification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.012 · Cited by 895
Ikemura, T. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90363-6 · Cited by 875
Grosjean, H., & Fiers, W. (1982) · Gene · doi:10.1016/0378-1119(82)90157-3 · Cited by 851
Hearing silence: non-neutral evolution at synonymous sites in mammals
Chamary, J. V., Parmley, J. L., & Hurst, L. D. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1770 · Cited by 831
Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation
Doma, M. K., & Parker, R. (2006) · Nature · doi:10.1038/nature04530 · Cited by 760
Is the multidrug transporter a flippase?
Higgins, C. F., & Gottesman, M. M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90419-a · Cited by 722
Self-citationThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.2.2463300 · Cited by 604
Self-citationHsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis
Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.043 · Cited by 601
Predicting drug sensitivity and resistance
Szakács, G., Annereau, J.-P., Lababidi, S., Shankavaram, U., Arciello, A., Bussey, K. J., Reinhold, W., Guo, Y., Kruh, G. D., Reimers, M., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.026 · Cited by 531
Self-citationFollowing translation by single ribosomes one codon at a time
Wen, J.-D., Lancaster, L., Hodges, C., Zeri, A.-C., Yoshimura, S. H., Noller, H. F., Bustamante, C., & Tinoco, I. (2008) · Nature · doi:10.1038/nature06716 · Cited by 492
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L., & Sadée, W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000178311.02878.83 · Cited by 490
ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
Self-citationThe catalytic cycle of P‐glycoprotein
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01345-8 · Cited by 440
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.
Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39690-5 · Cited by 387
Self-citationA pause for thought along the co-translational folding pathway
Komar, A. A. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.10.002 · Cited by 349
Functional involvement of P-glycoprotein in blood-brain barrier.
Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., & Tsuruo, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88713-6 · Cited by 347
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334
Lankas, G. R., Wise, L. D., Cartwright, M. E., Pippert, T., & Umbenhauer, D. R. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00027-6 · Cited by 314
Leschziner, G. D., Andrew, T., Pirmohamed, M., & Johnson, M. R. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500413 · Cited by 300
Tang, K., Ngoi, S.-M., Gwee, P.-C., Chua, J. M. Z., Lee, E. J. D., Chong, S. S., & Lee, C. G. L. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00004 · Cited by 285
Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.
Chen, C. J., Clark, D., Ueda, K., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40260-3 · Cited by 269
Self-citationNakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M., & Okumura, K. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.122055 · Cited by 260
Sharom, F. J., Yu, X., & Doige, C. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80510-9 · Cited by 256
Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein
Loo, T. W., & Clarke, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.843 · Cited by 252
Synonymous Mutations and Ribosome Stalling Can Lead to Altered Folding Pathways and Distinct Minima
Tsai, C.-J., Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., Gottesman, M. M., & Nussinov, R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.012 · Cited by 252
Self-citationMDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer, T., Schuler, U. S., Thiede, C., Schwarz, U. I., Kim, R. B., Gotthard, S., Freund, D., Schäkel, U., Ehninger, G., & Schaich, M. A. (2002) · PubMed · Cited by 248
Siegsmund, M., Brinkmann, U., Scha[Combining Acute Accent]ffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019412.87412.bc · Cited by 246
Silent Polymorphisms Speak: How They Affect Pharmacogenomics and the Treatment of Cancer
Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., & Gottesman, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2377 · Cited by 243
Self-citationThe power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Loo, T. W., & Clarke, D. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53670-x · Cited by 216
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
Schinkel, A. H., Kemp, S., Dollé, M., Rudenko, G., & Wagenaar, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53199-9 · Cited by 214
P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity
Lankas, G. R., Cartwright, M. E., & Umbenhauer, D. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8086 · Cited by 208
Kartner, N., Shales, M., Riordan, J. R., & Ling, V. W. T. (1983) · PubMed · Cited by 199
Goto, M., Masuda, S., Saito, H., Uemoto, S., Kiuchi, T., Tanaka, K., & Inui, K.-I. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00005 · Cited by 193
MDR1 Genotype-Related Pharmacokinetics and Pharmacodynamics.
Sakaeda, T., Nakamura, T., & Okumura, K. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1391 · Cited by 190
Salama, N. N., Yang, Z., Bui, T. O. T., & Ho, R. J. Y. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20717 · Cited by 189
Potočnik, U., Ferkolj, I., Glavač, D., & Dean, M. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364123 · Cited by 178
Loo, T. W., & Clarke, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21449 · Cited by 177
Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism
Eichelbaum, M., Fromm, M. F., & Schwab, M. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00017 · Cited by 176
Kioka, N., Tsubota, J., Kakehi, Y., Komano, T., Gottesman, M. M., Pastan, I., & Ueda, K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91985-2 · Cited by 175
Self-citationGermann, U. A., Chambers, T. C., Ambudkar, S. V., Licht, T., Cardarelli, C. O., Pastan, I., & Gottesman, M. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1708 · Cited by 172
Self-citationMDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin
Roulet, A., Puel, O., Gesta, S., Lepage, J.-F., Drag, M., Soll, M., Alvinerie, M., & Pineau, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02955-2 · Cited by 171
Kimchi‐Sarfaty, C., Gribar, J. J., & Gottesman, M. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.1 · Cited by 156
Self-citationAltered Drug-stimulated ATPase Activity in Mutants of the Human Multidrug Resistance Protein
Müller, M., Bakos, É., Welker, E., Váradi, A., Germann, U. A., Gottesman, M. M., Morse, B. S., Roninson, I. B., & Sarkadi, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1877 · Cited by 150
Self-citationDoige, C. A., Yu, X., & Sharom, F. J. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90078-z · Cited by 146
Sai, K., Kaniwa, N., Itoda, M., Saito, Y., Hasegawa, R., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Shirao, K., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00005 · Cited by 143
Sissung, T. M., Baum, C. E., Deeken, J. F., Price, D. K., Aragon‐Ching, J. B., Steinberg, S. M., Dahut, W. L., Sparreboom, A., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4230 · Cited by 140
Morrow, C. S., Smitherman, P. K., Diah, S. K., Schneider, E., & Townsend, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20114 · Cited by 139
Hitzl, M., Schaeffeler, E., Hocher, B., Slowinski, T., Halle, H., Eichelbaum, M. F., Kaufmann, P., Fritz, P., Fromm, M. F., & Schwab, M. G. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00006 · Cited by 137
Genomics refutes an exclusively African origin of humans
Eswaran, V., Harpending, H. C., & Rogers, A. R. (2005) · Journal of Human Evolution · doi:10.1016/j.jhevol.2005.02.006 · Cited by 136
Both ATP Sites of Human P-Glycoprotein Are Essential but Not Symmetric
Hrycyna, C. A., Ramachandra, M., Germann, U. A., Cheng, P. S. W., PASTAN, I., & Gottesman, M. M. (1999) · Biochemistry · doi:10.1021/bi991115m · Cited by 133
Self-citationGenetic dissection of the function of mammalian P-glycoproteins
Borst, P., & Schinkel, A. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01112-8 · Cited by 130
Moriya, Y., Nakamura, T., Horinouchi, M., et al. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1356 · Cited by 127
P‐glycoprotein: So Many Ways to Turn It On
Callaghan, R., Crowley, E. H., Biochem, M., Potter, S., & Kerr, I. D. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007311568 · Cited by 126
Disposition of Ivermectin and Cyclosporin A in CF-1 Mice Deficient in mdr1a P-Glycoprotein
Kwei, G. Y., Alvaro, R. F., Chen, Q., Jenkins, H. J., Hop, C. E. C. A., Keohane, C. A., Ly, V. T., Strauss, J. R., Wang, R. W., Wang, Z., et al. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15253-1 · Cited by 124
Loo, T. W., & Clarke, D. M. (1994) · Biochemistry · doi:10.1021/bi00251a013 · Cited by 123
CYP450 pharmacogenetics for personalizing cancer therapy
van Schaik, R. H. N. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.03.002 · Cited by 123
Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities
Morita, N., Yasumori, T., & Nakayama, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00178-3 · Cited by 122
Soranzo, N., Gl, C., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., & Goldstein, D. B. (2004) · Genome Research · doi:10.1101/gr.1965304 · Cited by 118
Gribar, J. J., Ramachandra, M., Hrycyna, C. A., Dey, S., & Ambudkar, S. V. (2000) · The Journal of Membrane Biology · doi:10.1007/s002320001020 · Cited by 116
Kerr, K. M., Sauna, Z. E., & Ambudkar, S. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010044200 · Cited by 106
Sakurai, A., Onishi, Y., Hirano, H., Seigneuret, M., Obanayama, K., Kim, G., Liew, E. L., Sakaeda, T., Yoshiura, K.-I., Niikawa, N., et al. (2007) · Biochemistry · doi:10.1021/bi700330b · Cited by 103
Ethnicity-Related Polymorphisms and Haplotypes in the Human ABCB1 Gene
Kimchi‐Sarfaty, C., Marple, A., Shinar, S., Kimchi, A. M., Scavo, D., Roma, M. I., Kim, I., Jones, A., Arora, M., Gribar, J. J., et al. (2006) · Pharmacogenomics · doi:10.2217/14622416.8.1.29 · Cited by 101
Self-citationZhang, X., Collins, K. I., & Greenberger, L. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5441 · Cited by 100
Genomic evidence for recent positive selection at the human MDR1 gene locus
Tang, K., Wong, L.-P., Lee, E. J. D., Chong, S. S., & Lee, C. G. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh099 · Cited by 95
The chemistry of protein synthesis and voyage through the ribosomal tunnel
Jenni, S., & Ban, N. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00034-4 · Cited by 93
Localization of multidrug resistance-associated DNA sequences to human chromosome 7
Fojo, A. T., Lebo, R. V., Shimizu, N., et al. (1986) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01570737 · Cited by 92
Kajiji, S. M., Talbot, F., Grizzuti, K., Dyke-Phillips, V. V., Agresti, M., Safa, A. R., & Gros, P. (1993) · Biochemistry · doi:10.1021/bi00067a005 · Cited by 92
Control of SecA and SecM translation by protein secretion
Nakatogawa, H., Murakami, A., & Ito, K. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.01.001 · Cited by 90
Urbatsch, I. L., Gimi, K., Wilke-Mounts, S., & Senior, A. E. (2000) · Biochemistry · doi:10.1021/bi001220s · Cited by 72
Owen, A., Goldring, C. E., Morgan, P., et al. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02229.x · Cited by 72
Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein
Woodahl, E. L., Yang, Z., Bui, T., Shen, D. D., & Ho, R. J. Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065383 · Cited by 72
Leschziner, G. D., Zabaneh, D., Pirmohamed, M., Owen, A., Rogers, J., Coffey, A. J., Balding, D. J., Bentley, D., & Johnson, M. R. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000197467.21964.67 · Cited by 71
Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms
Gow, J. M., Hodges, L. M., Chinn, L. W., & Kroetz, D. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135194 · Cited by 62
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children
Wasilewska, A. M., Zalewski, G., Chyczewski, L., et al. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0275-3 · Cited by 59
Kim, I., Peng, X.-H., Sauna, Z. E., FitzGerald, P. C., Xia, D., Müller, M., Nandigama, K., & Ambudkar, S. V. (2006) · Biochemistry · doi:10.1021/bi060308o · Cited by 59
Jeong, H., Herskowitz, I., Kroetz, D. L., & Rine, J. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030039 · Cited by 58
Wen, J., & Brogna, S. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360514 · Cited by 54
Increase of P-glycoprotein-mediated drug resistance by hsp 90b
Bertram, J., Palfner, K., Hiddemann, W., & Kneba, M. (1996) · Anti-Cancer Drugs · doi:10.1097/00001813-199611000-00004 · Cited by 49
Purification and reconstitution of functional human P-glycoprotein
Ambudkar, S. V. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110327 · Cited by 47
Saito, K., Miyake, S., Moriya, H., Yamazaki, M., Itoh, F., Imai, K., Kurosawa, N., Owada, E., & Miyamoto, A. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00092-4 · Cited by 41
Distribution of ABCB1 Polymorphisms Among Brazilians: Impact of Population Admixture
Estrela, R. D. C. E., Ribeiro, F. S., Carvalho, R. S., Gregorio, S. P., Dias‐Neto, E., Struchiner, C. J., & Suarez‐Kurtz, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.3.267 · Cited by 41
P-Glycoprotein is not present in mitochondrial membranes
Paterson, J. K., & GOTTESMAN, M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.04.019 · Cited by 37
Self-citationModulating the activity of the peptidyl transferase center of the ribosome
Beringer, M. (2008) · RNA · doi:10.1261/rna.980308 · Cited by 37
Ruth, A., Stein, W. D., Rose, E. A., & Roninson, I. B. (2001) · Biochemistry · doi:10.1021/bi001373f · Cited by 36
Potočnik, U., Glavač, D., & Dean, M. C. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.01.023 · Cited by 36
Pippert, T. R., & Umbenhauer, D. R. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.3 · Cited by 32
Transition-State Formation in ATPase-Negative Mutants of Human MDR1 Protein
Szakács, G., Özvegy‐Laczka, C., Bakos, É., Sarkadi, B., & Váradi, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3576 · Cited by 27
Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405623200 · Cited by 24
The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability
Gow, J. M., Chinn, L. W., & Kroetz, D. L. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017087 · Cited by 17
Cited by
Mechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
Self-citationVery important pharmacogene summary
Hodges, L. M., Markova, S. M., Chinn, L. W., Gow, J. M., Kroetz, D. L., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283385a1c · Cited by 436
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Wolking, S., Schaeffeler, E., Lerche, H., Schwab, M., & Nies, A. T. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0267-1 · Cited by 309
Stieger, B. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_5 · Cited by 269
Metadata
- Authors
- Fung, K. L., & Gottesman, M. M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 1794
- Issue
- 5
- Pages
- 860-871
- ISSN
- 1570-9639 (ISSN-L)
- OpenAlex
- W1991205228
- Cited by
- 335
- References
- 108
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.